Structure-function relationship of serine protease-protein inhibitor interaction.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 11732612)

Published in Acta Biochim Pol on January 01, 2001

Authors

J Otlewski1, M Jaskólski, O Buczek, T Cierpicki, H Czapińska, D Krowarsch, A O Smalas, D Stachowiak, A Szpineta, M Dadlez

Author Affiliations

1: Institute of Biochemistry and Molecular Biology, University of Wrocław, Poland. otlewski@bf.uni.wroc.pl

Articles citing this

Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci (2007) 1.63

Discovery of a distinct superfamily of Kunitz-type toxin (KTT) from tarantulas. PLoS One (2008) 1.10

Molecular characterization of Ancylostoma ceylanicum Kunitz-type serine protease inhibitor: evidence for a role in hookworm-associated growth delay. Infect Immun (2004) 0.96

Evolution, expansion and expression of the Kunitz/BPTI gene family associated with long-term blood feeding in Ixodes Scapularis. BMC Evol Biol (2012) 0.93

SdPI, the first functionally characterized Kunitz-type trypsin inhibitor from scorpion venom. PLoS One (2011) 0.89

Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases. Protein Sci (2009) 0.89

pH dependence thermal stability of a chymotrypsin inhibitor from Schizolobium parahyba seeds. Biophys J (2005) 0.86

SjAPI, the first functionally characterized Ascaris-type protease inhibitor from animal venoms. PLoS One (2013) 0.82

Structural and functional parameters of the flaviviral protease: a promising antiviral drug target. Future Virol (2010) 0.81

Molecular insights into substrate specificity of prostate specific antigen through structural modeling. Proteins (2009) 0.81

Three genes expressing Kunitz domains in the epididymis are related to genes of WFDC-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products. BMC Biochem (2011) 0.80

Protease inhibitors from marine venomous animals and their counterparts in terrestrial venomous animals. Mar Drugs (2013) 0.79

Structure basis 1/2SLPI and porcine pancreas trypsin interaction. J Synchrotron Radiat (2013) 0.75

MP-4 Contributes to Snake Venom Neutralization by Mucuna pruriens Seeds through an Indirect Antibody-mediated Mechanism. J Biol Chem (2016) 0.75

Influence of Amitraz and Oxalic Acid on the Cuticle Proteolytic System of Apis mellifera L. Workers. Insects (2012) 0.75

Articles by these authors

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science (1989) 7.15

Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature (1989) 2.72

High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J Mol Biol (1995) 2.16

The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure (1996) 1.64

Molecular modeling of the HIV-1 protease and its substrate binding site. Science (1989) 1.60

Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci U S A (1993) 1.56

Canonical protein inhibitors of serine proteases. Cell Mol Life Sci (2003) 1.50

Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases. J Mol Biol (2000) 1.41

The crystal structures of the complexes between bovine beta-trypsin and ten P1 variants of BPTI. J Mol Biol (1999) 1.28

Comparative structural analysis of cytidine, ethenocytidine, and their protonated salts. I. Crystal and molecular structure of ethenocytidine. Nucleic Acids Res (1981) 1.23

Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases. J Mol Biol (1999) 1.12

Structural studies of cysteine proteases and their inhibitors. Acta Biochim Pol (2001) 1.05

Comparative structural analysis of cytidine, ethenocytidine and their protonated salts. II. IR spectral studies. Nucleic Acids Res (1982) 0.99

Conformational study of two synthetic peptides with sequence analogies to the N-terminal fragment of RNase A. Biophys Chem (1986) 0.94

High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence. J Mol Biol (2000) 0.93

Selection of potent chymotrypsin and elastase inhibitors from M13 phage library of basic pancreatic trypsin inhibitor (BPTI). Biochim Biophys Acta (2001) 0.91

Inhibition of six serine proteinases of the human coagulation system by mutants of bovine pancreatic trypsin inhibitor. J Biol Chem (2000) 0.89

Detergent-assisted oxidative folding of delta-conotoxins. J Pept Res (2003) 0.86

Specificity of human cathepsin G. Biochim Biophys Acta (1998) 0.86

Protein inhibitors of serine proteinases. Acta Biochim Pol (1999) 0.86

Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin. J Mol Biol (1998) 0.85

Fluorescence studies on association of human translation initiation factor eIF4E with mRNA cap-analogues. Z Naturforsch C (1999) 0.85

Squash inhibitor family of serine proteinases. Acta Biochim Pol (1996) 0.85

Comparative structural analysis of cytidine, ethenocytidine and their protonated salts III. 1H, 13C and 15N NMR studies at natural isotope abundance. Nucleic Acids Res (1984) 0.85

Two polymorphs of a covalent complex between papain and a diazomethylketone inhibitor. J Pept Res (2004) 0.85

Aspartic proteinase from Penicillium camemberti: purification, properties, and substrate specificity. Enzyme Microb Technol (1995) 0.82

Sequence determination and analysis of S-adenosyl-L-homocysteine hydrolase from yellow lupine (Lupinus luteus). Acta Biochim Pol (2001) 0.82

Crystallization and preliminary crystallographic studies of a new L-asparaginase encoded by the Escherichia coli genome. Acta Crystallogr D Biol Crystallogr (2000) 0.81

Stability of the residual structure in unfolded BPTI in different conditions of temperature and solvent composition measured by disulphide kinetics and double mutant cycle analysis. J Mol Biol (1999) 0.81

Synthesis, cloning and expression in Escherichia coli of a gene coding for the Met8-->Leu CMTI I--a representative of the squash inhibitors of serine proteinases. FEBS Lett (1995) 0.80

Primary structure and properties of the cathepsin G/chymotrypsin inhibitor from the larval hemolymph of Apis mellifera. Eur J Biochem (1999) 0.80

Sequence analysis of enzymes with asparaginase activity. Acta Biochim Pol (2001) 0.80

Why a "benign" mutation kills enzyme activity. Structure-based analysis of the A176V mutant of Saccharomyces cerevisiae L-asparaginase I. Acta Biochim Pol (1997) 0.79

Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction. Age (Dordr) (2013) 0.79

Expression, purification and preliminary crystallographic studies of human ketohexokinase. Acta Crystallogr D Biol Crystallogr (2001) 0.79

Identification of proteins co-purifying with scrapie infectivity. J Proteomics (2009) 0.79

Structural and energetic aspects of protein-protein recognition. Acta Biochim Pol (1997) 0.79

Structure-function relationships in serine protease-bovine pancreatic trypsin inhibitor interaction. Protein Pept Lett (2005) 0.78

Antiproteolytic activity of goose pancreas: purification, inhibitory properties and amino-acid sequence of a Kazal type trypsin inhibitor. Acta Biochim Pol (1996) 0.77

Preliminary crystallographic studies of Y25F mutant of periplasmic Escherichia coli L-asparaginase. Acta Biochim Pol (2000) 0.77

Crystallization and preliminary crystallographic studies of a new crystal form of Escherichia coli L--asparaginase II (Ser58Ala mutant). Acta Crystallogr D Biol Crystallogr (2000) 0.77

Unfolding kinetics of bovine trypsinogen. Eur J Biochem (1996) 0.76

Synthesis, conformation, and immunosuppressive activity of CLX and its analogues. Biopolymers (2003) 0.76

Inhibition of serine proteinases from human blood clotting system by squash inhibitor mutants. Biochim Biophys Acta (2000) 0.76

Isolation And Structure Elucidation Of 5,7-disubstituted Simple Coumarins In The Fruits Of Heracleum Mantegazzianum. Pharm Biol (2000) 0.76

Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity? Biochim Biophys Acta (1999) 0.75

Phage display selection of P1 mutants of BPTI directed against five different serine proteinases. Biol Chem (1999) 0.75

Chemical modification of adenine and cytosine residues with chloroacetaldehyde at the nucleoside and the tRNA level: the structural effect of chloroacetaldehyde modification. IARC Sci Publ (1986) 0.75

Crystallization and preliminary crystallographic studies of a new crystal form of papain from Carica papaya. Acta Biochim Pol (1997) 0.75

Enhancement of chymotrypsin-inhibitor/substrate interactions by 3 M NaCl. Biochim Biophys Acta (2001) 0.75

Molecular recognition motifs in cytidinium and 2'-deoxycytidinium salts with composite anions. Acta Biochim Pol (1998) 0.75

Crystallization and preliminary x-ray structure determination of Lupinus luteus PR10 protein. Acta Crystallogr D Biol Crystallogr (1999) 0.75

Crystal chemistry of some synthetic 2-oxa-steroids: conformation, packing motifs and isostructurality. Acta Crystallogr B (2000) 0.75